Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured article: Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach

The SARS-CoV-2 outbreak originating in Wuhan has raised global health concerns and the pandemic has now been reported on all inhabited continents. Aftab and colleagues designed a study to devise new strategies for drug discovery and/or repositioning against SARS-CoV-2. The core objective of the study was to evaluate the potential of Galidesivir, similar to structurally similar antiviral compounds, to inhibit the viral replication protein RNA-dependent RNA polymerase. 

New Section: Translational medicines 'Ecosystem'

We are excited to announce the addition of a new section to Journal of Translational Medicine entitled Translational medicines 'Ecosystem'. 


Led by Section Editor Vijay Mahant, this exciting new section aims to provide a forum for the topics spanning the translational research ecosystem beyond academia. 

Particular focus area will include opportunities and challenges in collaborating with industry and the role of stakeholders in the translational research “ecosystem”.

Journal of Translational Medicine has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funders and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review.

Read More

Trending articles

Check out the most discussed articles from Journal of Translational Medicine in the past 6 months!

Articles

  1. Authors: Thomas E Ichim, Fabio Solano, Eduardo Glenn, Frank Morales, Leonard Smith, George Zabrecky and Neil H Riordan

    Content type: Review

Editor-in-Chief

Francesco Marincola, Refuge Biotechnologies, USA

Featured Section

Translational hematology- Edited by Seah H. Lim

Featured Section TM_ImageThis section will provide an international platform for presentation of high quality clinical and laboratory translational research, bridging the gap between basic research and pure clinical studies. The scope includes clinical and clinico-pathological investigations and fundamental research of translational potential in hematologic diseases. These include studies in red blood cells, white blood cells, platelets, coagulation, transfusion medicine, and cellular therapy.

Translational Medicine Communications is the companion journal of Journal of Translational Medicine

Translational Medicine Communications is an interdisciplinary forum for all scientifically valid research from across translational medicine. The journal aims to improve transparency and reproducibility within translational medicine and considers research papers regardless of outcome or significance of findings.

Explore the companion journal

Aims and scope

Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science.

The journal covers all areas of translational medicine but also has several special sections:

Annual Journal Metrics